19
1
49
2
2
18
1b
1d
18
31
7c
1d
2 29
1d
25
Jacquelyn Crane, MD
88
7c
Assistant Professor of Pediatrics (Oncology) at the Children's Hospital of Philadelphia
7
61
Department: Pediatrics
4
1
b
1d
46
Contact information
50
4
3
3
3
2
4
b
1f
50
The Hub for Clinical Collaboration
1f 3500 Civic Center Blvd
2e Office 3547
Philadelphia, PA 19104
26
1f 3500 Civic Center Blvd
2e Office 3547
Philadelphia, PA 19104
35
f
13
Education:
21 8 B.A 17 (Psychology) c
2a Dartmouth College, 2008.
21 9 M.D. c
3c Tufts University School of Medicine, 2014.
c
3
3
3
3
8d
Permanent link21 8 B.A 17 (Psychology) c
2a Dartmouth College, 2008.
21 9 M.D. c
3c Tufts University School of Medicine, 2014.
c
2 29
21
1e
1d
24
5e
71
e 29
27
Description of Clinical Expertise
7b I am focused on the care of children with solid tumors with a particular expertise in soft tissue sarcomas.71
Description of Research Expertise
7b My research focus is in the development and oversight of early phase clinical trials for pediatric cancers.e 29
23
14f Hu B, Kirkey D, Wakeling A, Danielle Kirkey, McGuinness M, Kreimer S, Crane J, Spunt S: Opportunities for Improving Detection of Cancer Predisposition Syndromes in Pediatric Solid Tumor Patients. Journal of Pediatric Hematology Oncology 46(6): 311-318, Aug 2024.
11d Hu B, Howitt BE, Cizek S, Diver E, Hiniker S, Crane J, Daldrup-Link H, Spunt SL.: Favorable Outcome of High-grade Endometrial Stromal Sarcoma in an Adolescent. J Pediatr Hematol Oncol 46(5): e334-e337, July 2024.
180 Oberoi S, Crane JN, Haduong JH, RudzinskI ER, Wolden SL, Dasgupta R, Linardic CM, Weiss AR, Venkatramani R on behalf of the Children’s Oncology Group Soft Tissue Sarcoma Committee: Children’s Oncology Group’s 2023 Blueprint for Research: Soft Tissue Sarcomas. Pediatr Blood Cancer 70(6): e30556, Sep 2023.
14f Crane JN, Graham DS, Mona CE, Nelson SD, Samiei A, Dawson DW, Dry SM, Masri MG, Crompton JG, Benz MR, Czernin J, Eilber FC, Graeber TG, Calais J, Federman NC: Fibroblast Activation Protein Expression in Sarcomas. Sarcoma 9(1): doi: 10.1155, Jun 2023 Notes: epub.
144 Alva HL, Ahn H, Zhao X, Obeidat M, Charu V, Crane JN, Marsenic O: A Case Report of Mediastinal Teratoma in a Pediatric Patient With Nephrotic Syndrome: Paraneoplastic Syndrome or Incidental Finding? J Pediatr Hematol Oncol 45(5): e631-e634, May 2023.
12b Crane JN, Donaldson SS, Spunt SL, Riniker SM: Comment on: Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single-center experience. Pediatr Blood Cancer 70(4): e30111, Dec 2022.
d4 Crane JN, Bergstrom, SK. : WAGR Syndrome. Medscape Drugs & Diseases. Available at: https://emedicine.medscape.com/article/989329. Oct 2022.
1ac Crane JN, Xue W, Qumseya A, Gao Z, Arndt CAS, Donaldson SS, Harrison DJ, Hawkins DS, Linardic CM, Mascarenhas L, Meyer WH, Rodeberg DA, Rudzinski ER, Shulkin BL, Walterhouse DO, Venkatramani R, Weiss AR: Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group. Pediatr Blood Cancer 69(9): e29644, Mar 2022.
144 Noah Federman, Kristiyana Kaneva, Jacquelyn Crane, Vivian Chang, Arun S. Singh, Nicholas M. Bernthal, Jane Yanagawa, Arya Ashok, Elizabeth Mauer: The genomic and immune landscape of osteosarcoma. Connective Tissue Oncology Society Annual Meeting 2022.
2c
7
1d
1f
Selected Publications
1ce Jonathan L. Metts*, Jamie M. Aye*, Jacquelyn N. Crane*, Sapna Oberoi*, Frank M. Balis, Smita Bhatia, , Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S. Dela Cruz, Katie A. Greenzang, Jonathan L. Kaufman, Corinne M. Linardic, Susan K. Parsons, Mark Robertson-Tessi, Erin R. Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J. Weigel, Suzanne L. Wolden, Aaron R. Weiss, Rajkumar Venkatramani, Christine M. Heske c7 *co first authors: Roadmap for the Next Generation of Children’s Oncology Group Rhabdomyosarcoma Trials. Cancer 130(22): 3785-3796, Nov 2024 Notes: *co-first authors.14f Hu B, Kirkey D, Wakeling A, Danielle Kirkey, McGuinness M, Kreimer S, Crane J, Spunt S: Opportunities for Improving Detection of Cancer Predisposition Syndromes in Pediatric Solid Tumor Patients. Journal of Pediatric Hematology Oncology 46(6): 311-318, Aug 2024.
11d Hu B, Howitt BE, Cizek S, Diver E, Hiniker S, Crane J, Daldrup-Link H, Spunt SL.: Favorable Outcome of High-grade Endometrial Stromal Sarcoma in an Adolescent. J Pediatr Hematol Oncol 46(5): e334-e337, July 2024.
180 Oberoi S, Crane JN, Haduong JH, RudzinskI ER, Wolden SL, Dasgupta R, Linardic CM, Weiss AR, Venkatramani R on behalf of the Children’s Oncology Group Soft Tissue Sarcoma Committee: Children’s Oncology Group’s 2023 Blueprint for Research: Soft Tissue Sarcomas. Pediatr Blood Cancer 70(6): e30556, Sep 2023.
14f Crane JN, Graham DS, Mona CE, Nelson SD, Samiei A, Dawson DW, Dry SM, Masri MG, Crompton JG, Benz MR, Czernin J, Eilber FC, Graeber TG, Calais J, Federman NC: Fibroblast Activation Protein Expression in Sarcomas. Sarcoma 9(1): doi: 10.1155, Jun 2023 Notes: epub.
144 Alva HL, Ahn H, Zhao X, Obeidat M, Charu V, Crane JN, Marsenic O: A Case Report of Mediastinal Teratoma in a Pediatric Patient With Nephrotic Syndrome: Paraneoplastic Syndrome or Incidental Finding? J Pediatr Hematol Oncol 45(5): e631-e634, May 2023.
12b Crane JN, Donaldson SS, Spunt SL, Riniker SM: Comment on: Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single-center experience. Pediatr Blood Cancer 70(4): e30111, Dec 2022.
d4 Crane JN, Bergstrom, SK. : WAGR Syndrome. Medscape Drugs & Diseases. Available at: https://emedicine.medscape.com/article/989329. Oct 2022.
1ac Crane JN, Xue W, Qumseya A, Gao Z, Arndt CAS, Donaldson SS, Harrison DJ, Hawkins DS, Linardic CM, Mascarenhas L, Meyer WH, Rodeberg DA, Rudzinski ER, Shulkin BL, Walterhouse DO, Venkatramani R, Weiss AR: Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group. Pediatr Blood Cancer 69(9): e29644, Mar 2022.
144 Noah Federman, Kristiyana Kaneva, Jacquelyn Crane, Vivian Chang, Arun S. Singh, Nicholas M. Bernthal, Jane Yanagawa, Arya Ashok, Elizabeth Mauer: The genomic and immune landscape of osteosarcoma. Connective Tissue Oncology Society Annual Meeting 2022.
2c